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acrophages are concerned more with the shape than size of their 
victims when it comes to phagocytosis. The new ﬁ  ndings, reported 
by Julie Champion and Samir Mitragotri (University of California, 
Santa Barbara, CA), may inspire innovations in drug delivery strategies.
For this ﬁ  rst systematic examination of the effect of shape on phagocyto-
sis, Champion and Mitragotri synthesized their own IgG-coated polystyrene 
particles, using natural macrophage targets as inspirations (spherical and 
rod-shaped particles mimic bacteria, ﬂ  at discs resemble red blood cells, etc). 
Macrophages ingested each and every shape, but only if the target was initially encountered from the correct 
side—the one that required the most gradual expansion of the membrane as it englufed the particle.
“There is a right and a wrong shape from the macrophage’s perspective,” says Mitragotri. “If it attaches at 
the right angle, from the right side, it can take in something as large as itself.” From the wrong side, however, not 
even a particle 1/100th that size was taken in.
Mitragotri compares the phagocytosis of a rod to eating a sub sandwich. Starting off with the narrow end makes 
eating a snap, but if you tried eating it from the long, blunt side, you would have much more difﬁ  culty.
For us, that difﬁ  culty is opening our mouths wide enough. For the macrophage, the limitation seems to be 
actin-based membrane expansion. In successful phagocytosis, an actin cup formed underneath the object being 
engulfed and pushed the macrophage membrane forward uniformly. In unsuccessful attempts, actin cups did not 
form, and membrane movements were random and uneven, resembling cell spreading. The difference may reﬂ  ect 
the inability of actin to expand uniformly to cover the steeply increasing circumference of the object.
The ﬁ  ndings can be used to design drug carriers that offer some control over the degree of their phagocytosis. 
Vaccines, which should be taken in immediately, would do well in spherical vehicles. Drugs meant for sustained release, 
however, may be better offered in rods, which are only efﬁ  ciently internalized when they meet macrophages head-on.
Natural macrophage targets have much more complex surface chemistry than polystyrene particles, so 
Mitragotri expects there will be differences between real and artiﬁ  cial systems. But, he says, “shape will certainly 
come into the picture.” 
Reference: Champion, J.A., and S. Mitragotri. 2006. Proc. Natl. Acad. Sci. USA. doi:10.1073/pnas.0600997103.
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M
itochondria are synonymous with energy production. But new evidence from Marisol 
Quintero, Sergio Colombo, Andrew Godfrey, and Salvador Moncada (University 
College London, UK) suggests that mitochondria in the vascular endothelium are 
more signaling organelles than power plants.
Although vascular endothelial cells are crowded with mitochondria, these organelles are not 
the main ATP generators. Vascular endothelial cells are instead highly glycolytic, despite their 
close proximity to O2 in the blood. Moncada’s group had previously found that nitric oxide (NO), 
which is abundant in vascular endothelial cells, effi  ciently competes with O2 for the binding to 
the cytochrome c oxidase, the terminal enzyme in the mitochondrial respiratory chain.
In the new report, the authors show that, at relatively low O2 concentrations, this competition 
diverts O2 away from the mitochondria into the cytosol, thereby reducing the response of the cells 
to hypoxia. Much lower concentrations of O2 (0.5%) were required in endothelial cells to stabilize 
hypoxia-inducible factor (HIF)1α when compared with other cells. The diversion of O2 and the 
decrease in HIF1α stabilization might help to maintain endothelial cells in a nonangiogenic state 
for proper vascular smooth muscle oxygenation.
In addition, the authors show that the competition between NO and O2 generates reactive 
oxygen species (ROS) as a result of a backlog of electrons in the respiratory chain. The ROS 
activated AMP-activated protein kinase (AMPK), an enzyme that promotes better use of energy 
by activating catabolic pathways and repressing anabolic ones. Moncada has not yet shown the 
physiological outcome of AMP kinase activation, but it might turn on defensive responses. 
Reference: Quintero, M., et al. 2006. Proc. Natl. Acad. Sci. USA. doi:10.1073/pnas.0601026103.
Phagocytosis succeeds if a cell (brown) meets a 
rod-shaped particle (purple) end-on (left), but not 
side-ﬁ  rst (right).
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At low O2 (top), endothelial mito-
chondria make ROS that activate 
AMP kinase.
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